An overview of domestic and international clinical trials for delivery of cellular therapies to the spinal cord

Clinical Neurosurgery

Volumn 59, Issue , 2012, Pages 98-104

  Riley, Jonathan ^a   Taub, Jason ^a   Raore, Bethwel ^a   Boulis, Nicholas M ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NATALIZUMAB; RILUZOLE;

AMERICAN SPINAL INJURY ASSOCIATION IMPAIRMENT SCALE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL THERAPY; CLINICAL TRIAL (TOPIC); HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; MYELINATION; NEURAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RESEARCH ETHICS; RISK FACTOR; SPINAL CORD; SPINAL CORD DECOMPRESSION; SPINAL CORD INJURY; SPINAL MUSCULAR ATROPHY; SPINE STABILIZATION; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; DEGENERATIVE DISEASE; METHODOLOGY; REVIEW; SPINAL CORD DISEASE;

CLINICAL TRIALS AS TOPIC; HUMANS; NEURODEGENERATIVE DISEASES; SPINAL CORD DISEASES; STEM CELL TRANSPLANTATION;

EID: 84868244273     PISSN: 00694827     EISSN: 0148396X     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31826b2eee     Document Type: Article

References (23)

1. Knoller N, Auerbach G, Fulga V, et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results. J Neurosurg Spine. 2005;3(3):173-181.
2. Huang H, Chen L, Wang H, et al. Safety of fetal olfactory ensheathing cell transplantation in patients with chronic spinal cord injury: a 38-month follow-up with MRI. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006;20(4):439-443.
3. Mazzini L, Mareschi K, Ferrero I, et al. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy. 2012;14(1):56-60.
4. Mazzini L, Mareschi K, Ferrero I, et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci. 2008;265(1-2):78-83.
5. Huang H, Chen L, Wang H, et al. Influence of patients' age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl). 2003;116(10):1488-1491. (Pubitemid 37461660)
6. Chen L, Huang H, Zhang J, et al. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2007;21(9):961-966.
7. Féron F, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005;128(pt 12):2951-2960. (Pubitemid 41746648)
8. Deda H, Inci MC, Kürekçi AE, et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy. 2009;11(1):18-25.
9. Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells. 2007;25(8):2066-2073.
10. Mazzini L, Ferrero I, Luparello V, et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol. 2010;223(1):229-237.
11. Blanquer M, Moraleda JM, Iniesta F, et al. Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study. Stem Cells. 2012;30(6):1277-1285.
12. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461-467.
13. Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury. http://www.clinicaltrials.gov/ct2/show/NCT01162915? term=NCT01162915&rank=1. Accessed April 23, 2012.
14. Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis (ALS). http://www.clinicaltrials.gov/ct2/show/NCT01142856? term= NCT01142856&rank=1. Accessed April 23, 2012.
15. Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients. http://www.clinical trials.gov/ct2/show/NCT01051882?term=NCT01051882&rank=1. Accessed April 23, 2012.
16. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651-660. (Pubitemid 40320700)
17. Glass JD, Boulis NM, Johe K, et al. Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells. 2012;30(6):1144-1151.
18. Riley J, Federici T, Polak M, et al. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery. 2012;71(2):405-416.
19. Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS). http://www.clinicaltrials.gov/ ct2/show/NCT01348451?term=NCT01348451&rank=1. Accessed April 23, 2012.
20. California Stem Cell. News. http://www.californiastemcell.com/cgi-bin/ pressrel?20101201. Accessed May 21, 2012.
21. Cox CS Jr, Baumgartner JE, Harting MT, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;68(3):588-600.
22. Riley JP, Raore B, Taub JS, Federici T, Boulis NM. Platform and cannula design improvements for spinal cord therapeutics delivery. Neurosurgery. 2011;69(2 suppl operative):ons147-ons154; discussion ons155.
23. Monte Tabor Hospital Sao Rafael. Stem cells. http://www.cbtc-hsr.org/en/ not.php?id=soDD5igR2Nbw6PkJwY3/1hfO1v33js6qyu1+etVyFSs=. Accessed May 21, 2012.